<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report: May 31, 2000
(Date of earliest event reported)
MEDICAL ACTION INDUSTRIES INC.
(Exact name of registrant as specified in its charter)
Delaware 0-13251 11-2421849
(State or other (Commission File Number) (IRS Employer
jurisdiction of Identification
incorporation) Number)
150 Motor Parkway, Hauppauge, New York 11788
(Address of principal executive offices) (Zip Code)
Registrant's telephone number
including area code (516) 231-4600
(Former name or former address, if changed since last report)
<PAGE>
Item 5. Other Events
On May 31, 2000, the Registrant and Paul D. Meringolo entered
into an agreement modifying Mr. Meringolo's Employment Agreement dated February
1, 1993, as modified on February 5, 1996, May 28, 1997 and July 21, 1999. The
Modification Agreement extended the term of Mr. Meringolo's employment Agreement
to and including March 31, 2005 and increased the base salary thereunder to
$250,000.
Item 7. Financial Statements, Pro Forma Financial Information
and Exhibits
(c) Exhibits
(10) Modification Agreement dated as of May 31, 2000.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
MEDICAL ACTION INDUSTRIES INC.
By: /s/ Richard G. Satin
----------------------------------------
Richard G. Satin, Vice President -
Operations and General Counsel
(Principal Accounting Officer)
Dated: June 5, 2000
